Cargando…
Recent Insights on Genetic Testing in Primary Prostate Cancer
Prostate cancer (PCa) is one of the most common cancers in developed countries. The results of large trials indicate that the proportion of PCa attributable to hereditary factors is as high as 15%, highlighting the importance of genetic testing. Despite improved understanding of the prevalence of pa...
Autores principales: | Kafka, Mona, Surcel, Cristian, Heidegger, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249272/ https://www.ncbi.nlm.nih.gov/pubmed/34118026 http://dx.doi.org/10.1007/s40291-021-00529-3 |
Ejemplares similares
-
Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers?
por: Surcel, Cristian, et al.
Publicado: (2022) -
Recent Scientific Developments in Metastatic Prostate Cancer
por: Heidegger, Isabel
Publicado: (2020) -
Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response
por: Kafka, Mona, et al.
Publicado: (2022) -
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
por: Ladurner, Michael, et al.
Publicado: (2021) -
ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)